Brian Sabol Patient

Brian was diagnosed with multiple myeloma in 2015, and since then has experienced a variety of treatments. He credits the work of the MMRF for making those treatments available, and now is enthusiastically joining up with the MMRF and Janssen Oncology for the Vermont to Quebec challenge. Brian heard about the R2V program through patient friend and fellow rider Tim Nash. These two are looking forward to cycling together and supporting one another both on the road and back home in their support group.

Grateful…And Paying it Forward
Brian Sabol
If it weren’t for the research spearheaded by the Multiple Myeloma Research Foundation (MMRF), I might not have been here to write this blog and take part in this ride.
Read More
How I got involved with The MMRF
Brian Sabol
Sitting and staring at a blank sheet of (virtual) paper thinking: “You’ve never blogged, never done anything on Social Media, and never have done anything like this before. What were…
Read More
The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients. To learn more, visit

Learn More

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more About Johnson & Johnson inovative medicine Learn more About Johnson & Johnson Follow us on @JanssenUS And @JNJInnovMed